Results 171 to 180 of about 30,205 (229)

Universal Use of Novel Oral Anticoagulant Prophylaxis in Myeloma Patients Undergoing IMiD-Based Therapy: Real-World Experience. [PDF]

open access: yesJ Clin Med
Mutlu YG   +8 more
europepmc   +1 more source

Thromboprophylaxis in multiple myeloma

open access: yesResearch and Practice in Thrombosis and Haemostasis
openaire   +3 more sources

Prothrombin G20210A and Factor V Leiden Variants Are Not Associated With Thrombotic Events in Congenital Heart Disease: An Observational Trial. [PDF]

open access: yesJ Am Heart Assoc
Ladha FA   +16 more
europepmc   +1 more source

Thromboembolism and bleeding in newly diagnosed multiple myeloma: rates, risk profile, and patterns of thromboprophylaxis. [PDF]

open access: yesRes Pract Thromb Haemost
Vospernik L   +10 more
europepmc   +1 more source

Postinjury thromboprophylaxis

Current Opinion in Critical Care, 2008
In trauma patients, pulmonary embolism occurs in up to 4% of cases and carries a mortality of 20-50%. The incidence of deep vein thrombosis (DVT) varies from 5 to 63% depending on patients' risk factors, modality of prophylaxis, and methods of detection.
Bendinelli, Cino, Balogh, Zsolt
openaire   +2 more sources

Thromboprophylaxis in Microsurgery

Acta Chirurgica Belgica, 2006
Microsurgical free tissue transfer has become a gold standard in a wide range of clinical situations. Thrombosis at the anastomotic site is not only the most common cause of failure of microsurgical operations, but it is also one of the factors resulting in microcirculatory intravascular thrombosis in free flaps.
Lecoq, Jean-Pierre   +4 more
openaire   +2 more sources

Thromboprophylaxis

2023
Abstract Summary Venous thromboembolism (VTE) is a global health burden of which critically unwell patients are at high risk. Current accepted practice and background evidence for the use of mechanical and pharmacological prophylaxis are reviewed.
Emma Louise Hartley, Andrew Retter
openaire   +1 more source

Home - About - Disclaimer - Privacy